Spero Therapeutics, Inc. Deferred Rent Credit, Current
Spero Therapeutics, Inc. (SPRO) had Deferred Rent Credit, Current of $229.00 thousand as of 2018-12-31, per its 10-K filed 2020-03-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRentCreditCurrent · last filed 2020-03-16
- 2018-12-31: Deferred Rent Credit, Current $229.00K.
- 2018-09-30: Deferred Rent Credit, Current $127.00K.
- 2018-06-30: Deferred Rent Credit, Current $126.00K.
- 2018-03-31: Deferred Rent Credit, Current $145.00K.
| Period end | Deferred Rent Credit, Current |
|---|---|
| 2018-12-31 | $229.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $127.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $126.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $145.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $143.00K 10-K · filed 2019-03-14 |
| 2017-09-30 | $142.00K 10-Q · filed 2017-12-14 |
| 2016-12-31 | $143.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |